

1,402,110 filings since 2004 · latest accepted Nov 4, 2026, 11:50 AM ET
Priority items usually mark a change in credit, accounting integrity, control or listing status: 1.02 Agreement terminated, 1.03 Bankruptcy, 1.05 Cybersecurity incident, 2.04 Debt acceleration, 2.05 Restructuring costs, 2.06 Impairment, 3.01 Delisting notice, 4.01 Auditor change, 4.02 Non-reliance (restatement), 5.01 Change in control.
| Filed | Company | Items | Filing |
|---|---|---|---|
Dec 31, 2025 accepted 9:30 PM ET | ORMPORAMED PHARMACEUTICALS INC. | 5.02Officer / director change | DocumentSEC ↗ |
Aug 21, 2025 accepted 8:06 PM ET | ORMPORAMED PHARMACEUTICALS INC. | Officer / director change |
Source: SEC EDGAR. Same-day filings appear within minutes and are re-checked against SEC's nightly index. Tickers are current listings, so a company's older filings show its ticker today.
| DocumentSEC ↗ |
Jun 10, 2024 accepted 9:28 PM ET | ORMPORAMED PHARMACEUTICALS INC. | 5.02Officer / director change | DocumentSEC ↗ |
May 13, 2024 accepted 10:00 PM ET | ORMPORAMED PHARMACEUTICALS INC. | 5.02Officer / director change | DocumentSEC ↗ |
Mar 18, 2024 accepted 9:15 PM ET | ORMPORAMED PHARMACEUTICALS INC. | 5.02Officer / director change | DocumentSEC ↗ |
Jan 19, 2024 accepted 9:45 PM ET | ORMPORAMED PHARMACEUTICALS INC. | 5.02Officer / director change | DocumentSEC ↗ |
Dec 18, 2023 accepted 9:45 PM ET | ORMPORAMED PHARMACEUTICALS INC. | 5.02Officer / director change | DocumentSEC ↗ |
May 1, 2023 accepted 8:51 PM ET | ORMPORAMED PHARMACEUTICALS INC. | 5.02Officer / director change | DocumentSEC ↗ |
Apr 4, 2022 accepted 12:25 PM ET | ORMPORAMED PHARMACEUTICALS INC. | 5.02Officer / director change | DocumentSEC ↗ |